ASHPOfficial

This podcast will describe important considerations for health systems of varying size regarding the handling and distribution process of the COVID-19 vaccine. The listeners of this podcast, organized by the Section of Pharmacy Practice Leaders Advisory Group on Strategy & Industry Disruptors, will hear from three different health systems on their lessons learned regarding the allocation of the COVID19 vaccine.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Vicki Basalyga, ASHP Director of Clinical Specialists and Scientists, chats with team members from AMA and ASHP about the upcoming six-week summit and the combined efforts by both organizations to advance pharmacogenomics in the healthcare field.  

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Listen in as content matter experts share “pearls” of wisdom in this fast-paced, fun format.  This session features practitioners in Emergency Medicine and is brought to you by the Section of Clinical Specialists and Scientists Advisory Group on Emergency Medicine. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode will provide members a quick refresher on payer mandated alternative distribution models, commonly known as brown bagging and white bagging. We will review potential risks and benefits inherent to alternative distribution models and explain key factors motivating payers and manufacturers to adopt these methods. Finally, we will focus on certain situations where payer mandated policies can negatively affect patient care and what can be done to avoid such scenarios. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The ASHP Specialty Pharmacy State of Practice in Hospitals and Health Systems – Future Directions Summit will bring together key stakeholders to discuss how to advance health-system specialty pharmacy practice to optimize patient health outcomes. The interprofessional summit will feature focused discussions and recommendations on key areas in specialty pharmacy. Speakers will share an outline of the summit and the anticipated outcomes. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In the first episode of “season two” of ASHP’s popular podcast with pharmacy leadership, host Paul Abramowitz, ASHP CEO, discusses the preliminary recommendations from the ASHP Task Force on Racial Diversity, Equity, and Inclusion with ASHP President Tom Johnson and Paul Walker, Chair of the Task Force. The ASHP leaders talk about the need to address the range of current and historical issues facing Black Americans, and to assess issues of intolerance and inequity that impact other minority groups represented within the organization’s membership and the overall profession of pharmacy. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In today's episode, the NYCSHP share their story & lessons learned in their wellbeing and resilience journey. Our speakers discuss how they have engaged their peers and chapter members in the prevention of burnout and building resilience during the pandemic.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This Midyear Clinical Meeting session led by Erin Fox and Jeff Little teaches how the listener how to compare legislative and regulatory advocacy issues at the state and nation level and recommend appropriate advocacy strategies for current patient care issues. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Through a series of podcasts, we will discuss the current state of Specialty Pharmacy during the COVID-19 pandemic and how specialty pharmacy practice has changed. During this podcast, we will discuss on-site and remote staffing models, rotating staff, and other staffing considerations during and beyond the pandemic. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In June 2020, a new consensus guideline was published in the American Journal of Health-System Pharmacy that changed therapeutic drug monitoring recommendations for vancomycin from troughs to AUC. This change has created significant controversy across the nation. Today, we are hoping to settle some of these controversies. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.